David J. Mazzo
Tracked across 1 events · 6 articles · First seen Sep 17, 2026 · Last active Sep 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Lisata Therapeutics acquired Marea Therapeutics, a clinical-stage biotechnology company developing next-generation medicines for cardioendocrine diseases, in a stock-for-stock transaction. All of Marea's outstanding equity interests were exchanged for 1,793,129 shares of Lisata common stock and…
Impact: Lisata CEO who framed the Marea acquisition as a milestone broadening the company into cardioendocrine diseases.
Sep 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track David J. Mazzo live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard